BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8950569)

  • 21. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.
    Mahenthiralingam E; Vandamme P; Campbell ME; Henry DA; Gravelle AM; Wong LT; Davidson AG; Wilcox PG; Nakielna B; Speert DP
    Clin Infect Dis; 2001 Nov; 33(9):1469-75. PubMed ID: 11588691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcome after acquisition of Burkholderia cepacia in patients with cystic fibrosis.
    McCloskey M; McCaughan J; Redmond AO; Elborn JS
    Ir J Med Sci; 2001; 170(1):28-31. PubMed ID: 11440408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial infection in cystic fibrosis (CF): special reference to mycobacteria and Burkholderia cepacia.
    Hodson ME
    Pediatr Pulmonol Suppl; 1995; 11():66-7. PubMed ID: 7547352
    [No Abstract]   [Full Text] [Related]  

  • 24. Exceptionally high representation of Burkholderia cepacia among B. cepacia complex isolates recovered from the major Portuguese cystic fibrosis center.
    Cunha MV; Pinto-de-Oliveira A; Meirinhos-Soares L; Salgado MJ; Melo-Cristino J; Correia S; Barreto C; Sá-Correia I
    J Clin Microbiol; 2007 May; 45(5):1628-33. PubMed ID: 17360834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
    Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
    J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre.
    Ledson MJ; Gallagher MJ; Jackson M; Hart CA; Walshaw MJ
    Thorax; 2002 Feb; 57(2):142-5. PubMed ID: 11828044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.
    Govan JR
    J R Soc Med; 2000; 93 Suppl 38(Suppl 38):40-5. PubMed ID: 10911818
    [No Abstract]   [Full Text] [Related]  

  • 28. Low incidence of pulmonary Pseudomonas cepacia infection in Danish cystic fibrosis patients.
    Nir M; Johansen HK; Høiby N
    Acta Paediatr; 1992 Dec; 81(12):1042-3. PubMed ID: 1283959
    [No Abstract]   [Full Text] [Related]  

  • 29. Burkholderia cepacia: another twist and a further threat.
    Webb AK; Govan JR
    Thorax; 1998 May; 53(5):333-4. PubMed ID: 9708220
    [No Abstract]   [Full Text] [Related]  

  • 30. Should patients with cystic fibrosis infected with Burkholderia cepacia undergo lung transplantation?
    Webb AK; Egan J
    Thorax; 1997 Aug; 52(8):671-3. PubMed ID: 9337823
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients.
    Kenna DTD; Lilley D; Coward A; Martin K; Perry C; Pike R; Hill R; Turton JF
    J Med Microbiol; 2017 Apr; 66(4):490-501. PubMed ID: 28463663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Burkholderia cepacia infections in cystic fibrosis.
    Burns JL; Saiman L
    Pediatr Infect Dis J; 1999 Feb; 18(2):155-6. PubMed ID: 10048690
    [No Abstract]   [Full Text] [Related]  

  • 33. Burkholderia cepacia complex infection in patients with cystic fibrosis.
    Mahenthiralingam E; Baldwin A; Vandamme P
    J Med Microbiol; 2002 Jul; 51(7):533-538. PubMed ID: 12132768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nosocomially acquired Pseudomonas cepacia infection in patients with cystic fibrosis.
    Tablan OC
    Infect Control Hosp Epidemiol; 1993 Mar; 14(3):124-6. PubMed ID: 7683030
    [No Abstract]   [Full Text] [Related]  

  • 35. Burkholderia cepacia genomovar III and Burkholderia vietnamiensis double infection in a cystic fibrosis child.
    Magalhães M; de Britto MC; Vandamme P
    J Cyst Fibros; 2002 Dec; 1(4):292-4. PubMed ID: 15463830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burkholderia cepacia--a transmissible cystic fibrosis pathogen.
    Burns JL
    J Pediatr; 2001 Nov; 139(5):618-9. PubMed ID: 11713434
    [No Abstract]   [Full Text] [Related]  

  • 37. Pseudomonas cepacia--more than a harmless commensal?
    Lancet; 1992 Jun; 339(8806):1385-6. PubMed ID: 1375968
    [No Abstract]   [Full Text] [Related]  

  • 38. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.
    Kiska DL; Kerr A; Jones MC; Caracciolo JA; Eskridge B; Jordan M; Miller S; Hughes D; King N; Gilligan PH
    J Clin Microbiol; 1996 Apr; 34(4):886-91. PubMed ID: 8815102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Burkholderia cepacia and cystic fibrosis--50 years on.
    Moore JE; Elborn JS
    Commun Dis Public Health; 2001 Jun; 4(2):114-6. PubMed ID: 11524998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cepacia syndrome occurring following prolonged colonisation with Burkholderia cepacia.
    Dobbin CJ; Soni R; Jelihovsky T; Bye PT
    Aust N Z J Med; 2000 Apr; 30(2):288-9. PubMed ID: 10833131
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.